Material Agreements

Idea Acquisition Corp. entered into Private Placement Warrants Purchase Agreement with the Representative (effective 2026-02-10).

“● A Private Placement Warrants Purchase Agreement, dated February 10, 2026, by and between the Company and the Representative”

Idea Acquisition Corp. entered into Private Placement Warrants Purchase Agreement with the Sponsor (effective 2026-02-10).

“● A Registration Rights Agreement, dated February 10, 2026, by and among the Company, the Sponsor and the holders signatory thereto, a copy of which is attached as Exhibit 10.3 hereto and is incorporated herein by reference.”

Idea Acquisition Corp. entered into Registration Rights Agreement with the Sponsor and the holders signatory thereto (effective 2026-02-10).

“● A Registration Rights Agreement, dated February 10, 2026, by and among the Company, the Sponsor and the holders signatory thereto”

Idea Acquisition Corp. entered into Investment Management Trust Agreement with Continental Stock Transfer & Trust Company (effective 2026-02-10).

“● An Investment Management Trust Agreement, dated February 10, 2026, by and between the Company and Continental, as trustee”

Idea Acquisition Corp. entered into Underwriting Agreement with Cantor Fitzgerald & Co. (effective 2026-02-10).

“● An Underwriting Agreement, dated February 10, 2026, by and between the Company and Cantor Fitzgerald & Co., as representative of the underwriters”

Spring Valley Acquisition Corp. IV entered into a equity purchase with the Sponsor (effective 2026-02-09).

“A Private Placement Warrants Subscription Agreement, dated February 9, 2026, between the Company and the Sponsor, a copy of which is filed as Exhibit 10.4 to this Report and incorporated herein by reference;”

Spring Valley Acquisition Corp. IV entered into a underwriting with Cohen and Company Capital Markets, a division of Cohen & Company Securities, LLC (“CCM”) and Clear Street LLC (“Clear Street”), as representatives of the underwriters named therein (effective 2026-02-09).

“An Underwriting Agreement, dated February 9, 2026, between the Company and Cohen and Company Capital Markets, a division of Cohen & Company Securities, LLC (“CCM”) and Clear Street LLC (“Clear Street”), as representatives of the underwriters named therein (the “Representatives”), a copy of which is filed as Exhibit 1.1 to this Current Report on Form 8-K (this “Report”) and incorporated herein by reference;”

HELIX ENERGY SOLUTIONS GROUP INC amended Amendment No. 2 with OneSubsea LLC, OneSubsea UK Limited, Schlumberger Technology Corporation, Schlumberger B.V. and Schlumberger Oilfield Holdings Ltd. (effective 2026-02-12).

“On February 12, 2026, Helix Energy Solutions Group, Inc. (“Helix”), OneSubsea LLC, OneSubsea UK Limited, Schlumberger Technology Corporation, Schlumberger B.V. and Schlumberger Oilfield Holdings Ltd. entered into an amendment (“Amendment No. 2”) to the Strategic Alliance Agreement entered into by the parties on January 5, 2015 (as amended, the “Alliance Agreement”).”

ATN International, Inc. entered into Transaction Agreement with EIP Holdings IV, LLC, an affiliate of Everest Infrastructure Partners, Inc. valued at up to $297 million in cash consideration (effective 2026-02-11).

“certain subsidiaries of ATN International, Inc. (the “ Company ”), including Commnet Wireless, LLC, Arizona Nevada Tower Company, LLC, Commnet Four Corners, LLC, Commnet of Arizona, LLC, Commnet of Nevada, LLC, Excomm, LLC, and Mora Valley Wireless, LLC (collectively, the “ Commnet Parties ” and, individually, each a “ Commnet Party ”), entered into that certain Purchase and Sale Agreement (the “ Transaction Agreement ”) with EIP Holdings IV, LLC, an affiliate of Everest Infrastructure Partners, Inc. (“ Everest ”) to sell approximately 214 tower portfolio sites”

ROYAL CARIBBEAN CRUISES LTD entered into Underwriting Agreement with J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and PNC Capital Markets LLC, as representatives of the several underwriters named in Exhibit A thereto valued at $1,250,000,000 aggregate principal amount of the Company’s 4.750% Senior Notes due 2033 and $1,250,0 (effective 2026-02-12).

“On February 12, 2026 , Royal Caribbean Cruises Ltd. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and PNC Capital Markets LLC, as representatives of the several underwriters named in Exhibit A thereto , relating to the issuance and sale by the Company of $1,250,000,000 aggregate principal amount of the Company’s 4.750% Senior Notes due 2033 and $1,250,000,000 aggregate principal amount of the Company’s 5.250% Senior Notes due 2038 in an underwritten public offering (the “Offering”) made pursuant to a registration statement and related prospectus supplement filed with the Securities and Exchange Commission.”

Hyperscale Data, Inc. entered into Sales Agreement with Wilson-Davis & Co., Inc. valued at up to $35,359.675 (effective 2026-02-13).

“On February 13, 2026, Hyperscale Data, Inc. (the “ Company ”) entered into an At-the-Market Issuance Sales Agreement (the “ Sales Agreement ”) with Wilson-Davis & Co., Inc., as sales agent (the “ Agent ”) to sell shares of its 13% Series D Cumulative Redeemable Perpetual Preferred Stock, par value $0.001 (the “ Preferred Stock ”), having an aggregate offering price of up to $35,359.675”

NEKTAR THERAPEUTICS entered into Underwriting Agreement with Jefferies LLC, TD Securities (USA) LLC, and Piper Sandler & Co. valued at approximately 432.0 million (effective 2026-02-11).

“On February 11, 2026, Nektar Therapeutics (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Jefferies LLC, TD Securities (USA) LLC, and Piper Sandler & Co. (collectively, the “Representatives”) as the representatives of the several underwriters named therein (the “Underwriters”), relating to an underwritten offering (the “Offering”)”

OLYMPIC STEEL INC terminated Third Amended and Restated Loan and Security Agreement with Bank of America, N.A., as administrative agent, and the Lenders.

“Item 1.02. Termination of a Material Definitive Agreement. In connection with the completion of the Merger, on the Closing Date, the Company terminated the Third Amended and Restated Loan and Security Agreement, dated as of December 8, 2017 (as amended, the “Credit Agreement”), by and among the Company, the Lenders (as defined therein), Bank of America, N.A., as administrative agent, and the other parties thereto.”

SYSCO CORP entered into Forty-Ninth Supplemental Indenture with U.S. Bank Trust Company, N.A. (effective 2026-02-13).

“of New York Mellon, as trustee, and the Forty-Eighth Supplemental Indenture thereto, dated as of February 13, 2026 (the “Forty-Eighth Supplemental Indenture”), by and among the Company, the Subsidiary Guarantors (as defined in the Supplemental Indentures) and U.S. Bank Trust Company, N.A. (the “Trustee”), as trustee thereunder solely with respect to the Notes, in lieu of Bank of New York Mellon.”

SYSCO CORP entered into Forty-Eighth Supplemental Indenture with U.S. Bank Trust Company, N.A. (effective 2026-02-13).

“stee, as supplemented and amended by the Thirteenth Supplemental Indenture thereto dated as of February 17, 2012 (the “Thirteenth Supplemental Indenture”), by and among the Company, the guarantors named therein and Bank of New York Mellon, as trustee, and the Forty-Eighth Supplemental Indenture thereto, dated as of February 13, 2026 (the “Forty-Eighth Supplemental Indenture”), by and among the Company, the Subsidiary Guarantors (as defined in the Supplemental Indentures) and U.S.”

AVADEL PHARMACEUTICALS PLC terminated Royalty Purchase Agreement with RTW Royalty II DAC valued at approximately $60,246,950 (effective 2026-02-12).

“On February 12, 2026, in connection with the Acquisition, Avadel exercised its option to prepay RTW Royalty II DAC (“RTW”) approximately $60,246,950 to terminate existing royalty payments and obligations pursuant to the Purchase and Sale Agreement, dated March 29, 2023, by and between Avadel, Avadel CNS Pharmaceuticals, LLC and RTW (the “Royalty Purchase Agreement”).”

AVADEL PHARMACEUTICALS PLC terminated Open Market Sale Agreement SM with Jefferies LLC (effective 2026-02-12).

“Effective as of February 12, 2026, in connection with the Acquisition (as defined below), Avadel Pharmaceuticals plc (“Avadel” or the “Company”) exercised its right to terminate the Open Market Sale Agreement SM , dated May 8, 2024, by and between Avadel and Jefferies LLC, with respect to an “at-the-market” offering program under which the Company could sell, from time to time, its ordinary shares.”

FRESH DEL MONTE PRODUCE INC entered into Asset Purchase Agreement with Del Monte Foods Holdings Limited and certain of its affiliates (collectively “Del Monte Foods”, acting in their capacity as the Seller thereunder) valued at $285 million plus assumption of certain liabilities (effective 2026-02-06).

“On February 6, 2026, the U.S. Bankruptcy Court for the District of New Jersey (the “Court”) entered a sale order and approved the Asset Purchase Agreement (the “Asset Purchase Agreement”) by and among Fresh Del Monte Produce Inc. (the “Company” or “FDP” acting in its capacity as the Buyer thereunder), Del Monte Foods Holdings Limited and certain of its affiliates (collectively “Del Monte Foods”, acting in their capacity as the Seller thereunder).”

BIOMARIN PHARMACEUTICAL INC entered into Indenture with U.S. Bank Trust Company, National Association, as trustee valued at $850 million aggregate principal amount (effective 2026-02-12).

“On February 12, 2026, BioMarin Pharmaceutical Inc. (BioMarin or the company) completed its previously-announced private placement of $850 million aggregate principal amount of 5.500% Senior Notes due 2026 (the Notes) to several investment banks acting as initial purchasers who subsequently resold the Notes to qualified institutional buyers as defined in Rule 144A under the Securities Act of 1933, as amended (the Securities Act) and outside the United States to non-U.S. persons pursuant to Regulation S under the Securities Act.”

XEROX CORP entered into Warrant Agreement with Computershare Inc. and Computershare Trust Company, N.A. valued at Warrants to purchase shares of Common Stock at $8.00 per share, expiring February 11, 2028 (effective 2026-02-12).

“On January 28, 2026, Xerox Holdings Corporation, a New York corporation (the “Company”), announced that the Board of Directors of the Company had declared a distribution (the “Warrants Distribution”) to the holders of record of the Company’s common stock, par value $1.00 per share (the “Common Stock”), the Company’s 3.75% Convertible Senior Notes due 2030 (the “Convertible Notes”) and the Company’s Series A Convertible Perpetual Voting Preferred Stock (the “Series A Preferred Stock”) in the form of warrants to purchase shares of Common Stock (the “Warrants”).”

SPS COMMERCE INC entered into Cooperation Agreement with Anson Funds Management LP (effective 2026-02-12).

“On February 12, 2026 , SPS Commerce, Inc. (the “Company”) entered into a cooperation letter agreement (the “Cooperation Agreement”) with Anson Funds Management LP (“Anson”).”

VerifyMe, Inc. entered into Agreement and Plan of Merger with Open World Ltd. (effective 2026-02-11).

“On February 11, 2026, VerifyMe, Inc., Nevada corporation (the “Company”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with VRME Subsidiary Corp., a Nevada corporation and wholly owned subsidiary of the Company (“Merger Sub”) and Open World Ltd., a Cayman Islands exempted company (“Open World”).”

CARNIVAL PLC amended Amendment No. 1 with JP Morgan Chase Bank, N.A. (effective 2026-02-12).

“On February 12, 2026, Carnival plc, a public limited company organized under the laws of England and Wales (the “Company”), entered into Amendment No. 1 (the “Amendment”) to the Amended and Restated Deposit Agreement, dated as of April 21, 2003 (the “Deposit Agreement”), among the Company, JP Morgan Chase Bank, N.A., as Depositary (the “Depositary”), and all holders from time to time of American Depositary Receipts (“ADRs”) issued thereunder.”

Cineverse Corp. entered into Purchase Agreement with certain lenders valued at $13,000,000 (effective 2026-02-12).

“On February 12, 2026, the Company entered into note purchase agreements (each, a “Purchase Agreement”) with certain lenders (individually, an “Investor” and collectively, the “Investors”), pursuant to which the Company agreed to issue and sell to the Investors convertible notes in the aggregate principal amount of $13,000,000 (each, a “Note”).”

Cineverse Corp. entered into Stock Purchase Agreement with John Marchesini, Nicholas Frazee, Michael Wanetik, Iurii Gorokhov, Kyrylo Shkodkin and Adtelligent Holdings Limited valued at $22,000,000 (effective 2026-02-12).

“On February 12, 2026, Cineverse Corp, (the “Company”) entered into a Stock Purchase Agreement (the “Agreement”) with John Marchesini, Nicholas Frazee, Michael Wanetik, Iurii Gorokhov, Kyrylo Shkodkin and Adtelligent Holdings Limited (collectively, the “Sellers”).”

HYUNDAI ABS FUNDING LLC entered into Underwriting Agreement with BofA Securities, Inc., on its own behalf and as representative of the several underwriters valued at $2,199,700,000 (effective 2026-02-10).

“On February 10, 2026, Hyundai ABS Funding, LLC (“HABS”), Hyundai Capital America (“HCA”) and BofA Securities, Inc., on its own behalf and as representative of the several underwriters (the “Underwriters”) entered into an Underwriting Agreement, pursuant to which notes in the following classes: Class A-1, Class A-2-A, Class A-2-B, Class A-3, Class A-4, Class B and Class C Asset Backed Notes (collectively, the “Notes”) with an aggregate principal balance of $2,199,700,000 were sold to the Underwriters.”

Axos Financial, Inc. entered into Agreement with SMBC MANUBANK valued at approximately $2.6 billion (effective 2026-02-12).

“On February 12, 2026, Axos Bank (the “Bank”), a subsidiary of Axos Financial, Inc. (the “Registrant”), entered into a purchase and assumption agreement (the “Agreement”) with SMBC MANUBANK (“SMBC”) to acquire all of the United States consumer deposits of Jenius Bank, a digital banking business of SMBC.”

CVR ENERGY INC amended Amendment with Wells Fargo Bank, National Association valued at increased the commitments under the Credit Facility from $345 million to $550 million (effective 2026-02-12).

“On February 12, 2026, certain subsidiaries of the Company (collectively, the “Borrowers”) and CVR Refining, LP (collectively with the Borrowers, the “Credit Parties”) entered into Amendment No. 5 to the Amended and Restated ABL Credit Agreement (the “Amendment”) with a group of lenders and Wells Fargo Bank, National Association (the “Agent”), as administrative agent and collateral agent.”

CVR ENERGY INC entered into Indenture with U.S. Bank Trust Company, National Association valued at $400 million in aggregate principal amount of 7.875% Senior Notes due 2034 (effective 2026-02-12).

“On February 12, 2026, CVR Energy, Inc. (the “Company”) completed the issuance of $600 million in aggregate principal amount of 7.500% Senior Notes due 2031 (the “2031 Notes”) and $400 million in aggregate principal amount of 7.875% Senior Notes due 2034 (the “2034 Notes” and, together with the 2031 Notes, the “Notes”) in a private offering pursuant to Rule 144A and Regulation S under the Securities Act of 1933, as amended. The Notes were issued under an Indenture, dated as of February 12, 2026 (the “Indenture”), among the Company, the subsidiary guarantors listed therein and U.S. Bank Trust Company, National Association, as trustee.”

CIM REAL ESTATE FINANCE TRUST, INC. amended Second Amendment to the Loan and Security Agreement with Ally Bank (effective 2026-02-06).

“On February 6, 2026 (the “Closing Date”), CMFT CL Lending Sub AB, LLC (the “Borrower”), an indirect wholly owned subsidiary of CIM Real Estate Finance Trust, Inc. (the “Company”), entered into that certain Second Amendment to the Loan and Security Agreement (the “Second Amendment”) with each of the lenders from time to time party thereto (the “Lenders”), Ally Bank (the “Bank”), as administrative agent and arranger (the “Administrative Agent”), and U.S. Bank Trust Company, National Association, as the collateral custodian (the “Collateral Custodian”), which amended the revolving loan and security agreement by and between the Borrower, Administrative Agent, Collateral Custodian, U.S. Bank National Association, as the document custodian, and Lenders, dated as of February 10, 2023”

Contango Silver & Gold Inc. entered into Underwriting Agreement with Canaccord Genuity LLC as representative of the several underwriters valued at approximately $47.2 million (effective 2026-02-11).

“On February 11, 2026, Contango ORE, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Canaccord Genuity LLC as representative of the several underwriters named therein, relating to an underwritten public offering to two institutional investors (the “Offering”) of (i) 1,678,206 shares (the “Shares”) of the Company’s common stock, $0.01 par value (the “Common Stock”), at a public offering price of $24.96 per share and (ii) a pre-funded warrant to purchase up to 325,000 shares of Common Stock (the “Pre-Funded Warrant”), at a purchase price of $24.95 per share with an exercise price of $0.01 per share.”

Alkermes plc. entered into Credit Agreement with JPMorgan Chase Bank, N.A., as Administrative Agent, Joint Lead Arranger and Joint Bookrunner, BofA Securities, Inc., as Joint Lead Arranger and Joint Bookrunner, and the lenders party thereto valued at $1.525 billion (effective 2026-02-12).

“On February 12, 2026, in connection with the Acquisition (as defined below), Alkermes plc (the “Company”) entered into a credit agreement (the “Credit Agreement”), by and among Alkermes plc, as the TopCo Borrower, Alkermes, Inc., as the U.S. Borrower, Alkermes Finance LLC, as the U.S. Co-Borrower, JPMorgan Chase Bank, N.A., as Administrative Agent, Joint Lead Arranger and Joint Bookrunner, BofA Securities, Inc., as Joint Lead Arranger and Joint Bookrunner, and the lenders party thereto.”

STORE CAPITAL LLC entered into Supplemental Indenture No. 7 with Wilmington Trust, National Association valued at $450.0 million aggregate principal amount (effective 2026-02-11).

“On February 11, 2026, STORE Capital LLC (the “ Company ”) completed its offering of $450.0 million aggregate principal amount of 4.95% Senior Notes due 2031 (the “ Notes ”) in a private offering that is exempt from the registration requirements of the Securities Act of 1933, as amended (the “ Securities Act ”). The terms of the Notes are governed by an indenture, dated as of March 15, 2018, between the Company and Wilmington Trust, National Association, as trustee (the “ Trustee ”), as supplemented by the Supplemental Indenture No. 7, dated as of February 11, 2026, between the Company and the Trustee (the base indenture, as so supplemented, the “ Indenture ”).”

TransUnion amended Amendment No. 25 with certain lenders valued at $400,000,000 (effective 2026-02-11).

“On February 11, 2026, TransUnion Intermediate Holdings, Inc. (“Holdings”), Trans Union LLC (the “Borrower”), certain wholly-owned subsidiaries of TransUnion (the “Company”), Deutsche Bank AG New York Branch, as the administrative agent and the collateral agent, and the lenders party thereto, entered into Amendment No. 25 (the “Amendment”) to the Third Amended and Restated Credit Agreement, dated as of August 9, 2017 (as amended, amended and restated, supplemented and/or otherwise modified from time to time, including pursuant to the Amendment, the “Credit Agreement”).”

AQUABOUNTY TECHNOLOGIES INC entered into Placement Agency Agreement with Univest Securities, LLC valued at 7.0% of the aggregate gross proceeds (effective 2026-02-11).

“On February 11, 2026, the Company entered into a Placement Agency Agreement (the “Placement Agency Agreement”) with Univest Securities, LLC (the “Placement Agent”), pursuant to which the Company engaged the Placement Agent to act as its exclusive placement agent on a reasonable best efforts basis. Under the Placement Agency Agreement, the Company has agreed to pay the Placement Agent a cash fee equal to 7.0% of the aggregate gross proceeds received by the Company in the Offering and to reimburse certain of the Placement Agent’s expenses, including legal fees, in an amount not to exceed $30,000.”

AQUABOUNTY TECHNOLOGIES INC entered into Securities Purchase Agreement with certain purchasers named therein valued at approximately $1,150,000 (effective 2026-02-11).

“On February 11, 2026, AquaBounty Technologies, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with certain purchasers named therein (the “Purchasers”), pursuant to which the Company agreed to issue and sell an aggregate of 1,269,509 shares of its common stock, par value $0.001 per share (the “Common Stock”), pre - funded warrants to purchase an aggregate of 67,706 shares of Common Stock (the “Pre-Funded Warrants”), and the 67,706 shares of Common Stock underlying the Pre-Funded Warrants (the “Pre-Funded Warrant Shares” and, together with the Pre-Funded Warrants and the Common Stock, the “Offering Securities”), at an offering price of $0.86 per share of Common Stock or $0.859 per Pre-Funded Warrant, as applicable, in a registered direct offering (the “Offering”).”

AB Private Credit Investors Corp amended Amendment with Pinnacle Bank, Specialty Finance Division valued at $150,000,000 (effective 2026-02-06).

“entered into an amendment (the “ Amendment ”) to the Loan Financing and Sale Agreement (the “ Loan Agreement ”) with Pinnacle Bank, Specialty Finance Division (formerly Synovus Specialty Finance Division)”

Insight Molecular Diagnostics Inc. entered into Placement Agency Agreement with Lake Street Capital Markets, LLC (effective 2026-02-10).

“The Company entered into a placement agency agreement (the “ Placement Agency Agreement ”), dated as of February 10, 2026, with Lake Street Capital Markets, LLC (the “ Placement Agent ”), pursuant to which the Placement Agent agreed to serve as the placement agent for the Company in connection with the Offering.”

Insight Molecular Diagnostics Inc. entered into Purchase Agreements with certain institutional investors valued at approximately $24.5 million (effective 2026-02-10).

“On February 10, 2026, Insight Molecular Diagnostics Inc. (the “ Company ”) entered into securities purchase agreements (the “ Purchase Agreements ”) with certain institutional investors, pursuant to which the Company agreed to issue and sell (i) 3,482,498 shares (the “ Shares ”) of the Company’s common stock, no par value per share (the “ Common Stock ”), and (ii) Pre-Funded Warrants (the “ Pre-Funded Warrants ”) to purchase up to 1,043,478 shares of Common Stock (the “ Pre-Funded Warrant Shares ”) in a registered direct offering (the “ Offering ”), pursuant to an effective shelf registration statement on Form S-3 (File No. 333-281159), a base prospectus and prospectus supplement relating to the Offering (the “ Prospectus Supplement ”), in each case filed with the Securities and Exchange Commission.”

FVCBankcorp, Inc. entered into Senior Unsecured Note Purchase Agreement with certain qualified institutional buyers and institutional accredited investors valued at $25.0 million aggregate principal amount of 6.75% Fixed Rate Senior Unsecured Notes due March 1, 202 (effective 2026-02-11).

“On February 11, 2026, FVCBankcorp, Inc. (the “Company”) entered into a Senior Unsecured Note Purchase Agreement (the “Purchase Agreement”) with certain qualified institutional buyers and institutional accredited investors pursuant to which the Company sold and issued an aggregate of $25.0 million in aggregate principal amount of Fixed Rate Senior Unsecured Notes due March 1, 2029 (the “Notes”) in a private placement.”

Southwest Gas Holdings, Inc. terminated Amended and Restated Cooperation Agreement with Carl C. Icahn and the persons and entities listed in the Cooperation Agreement (the “Icahn Group”) (effective 2026-02-11).

“On February 11, 2026, Southwest Gas Holdings, Inc. (the “Company”) and Carl C. Icahn and the persons and entities listed in the Cooperation Agreement (as defined below) (collectively, the “Icahn Group” and together with the Company, the “Parties”) mutually agreed to terminate that certain Amended and Restated Cooperation Agreement, dated as of October 14, 2025, by and between the Parties (the “Cooperation Agreement”).”

Solaris Energy Infrastructure, Inc. entered into Master Equipment Rental Agreement with Hatchbo, LLC valued at over 500 megawatts of power generation equipment (effective 2026-02-12).

“On February 12, 2026 (the “Effective Date”), Solaris Power Solutions, LLC, a Texas limited liability company (“Lessor”) and an indirect subsidiary of Solaris Energy Infrastructure, Inc., a Delaware corporation (the “Company”), entered into a Master Equipment Rental Agreement (the “Agreement”) with Hatchbo, LLC, a Delaware limited liability company and an affiliate of an investment grade, global technology company and industry leader in the evolving artificial intelligence computing space (the “Customer”), pursuant to which Lessor has agreed to provide over 500 megawatts of power generation equipment (the “Equipment”) to support Customer’s power demand for artificial intelligence computing needs at its data centers.”

Sadot Group Inc. entered into Securities Purchase Agreement with Stanley Hills, LLC valued at $145,244 (effective 2026-02-11).

“On February 11, 2026, Sadot Group Inc. (the “Company”) entered into a Securities Purchase Agreement (the “SPA”) with Stanley Hills, LLC (the “Purchaser”), pursuant to which the Company agreed to issue and sell to the Purchaser 10,000 shares of the Company’s newly designated Series A Preferred Stock, par value $0.0001 per share (the “Series A Preferred Stock”), for an aggregate purchase price of $145,244”

Catheter Precision, Inc. entered into Series J Exchange Agreements with David A. Jenkins and FatBoy Capital, LP valued at $9,489,487.81 (effective 2026-02-12).

“On February 12, 2026, Catheter Precision, Inc., a Delaware corporation (the "Company"), entered into Series J Exchange Agreements (the "Exchange Agreements") with David A. Jenkins and FatBoy Capital, LP. (the "Holders") to convert royalty rights and accrued royalty right amounts into 2,491.293 shares and 6,998.195 shares, respectively of the Company's newly created Series J Convertible Preferred Stock”

Beam Therapeutics Inc. entered into Standby License Agreement with Kobe University and Bio Palette Co., Ltd. (effective 2026-02-09).

“on February 9, 2026, the Company entered into a standby license agreement (the “Standby License Agreement”) with Kobe and Bio Palette.”

Tectonic Financial, Inc. entered into Subordinated Note Purchase Agreements with certain institutional accredited investors and qualified institutional buyers valued at $40 million in aggregate principal amount of its 7.25% Fixed-to-Floating Rate Subordinated Notes due (effective 2026-02-11).

“On February 11, 2026, Tectonic Financial, Inc. (the “Company”), the parent company for T Bank, National Association (the “Bank”), entered into Subordinated Note Purchase Agreements (the “Purchase Agreements”) with certain institutional “accredited investors,””

Onconetix, Inc. entered into Share Exchange Agreement with Realbotix Corp., Simulacra Corporation, and Realbotix, LLC (effective 2026-02-11).

“On February 11, 2026, Onconetix, Inc, a Delaware corporation (“ Onconetix ” or “ Buyer ”), entered into a Share Exchange Agreement (the “ Share Exchange Agreement ”), by and among (i) Onconetix, (ii) Realbotix Corp., a company existing under the laws of the Province of Ontario (“ Parent ”), (iii) Simulacra Corporation, a Delaware corporation and a wholly-owned subsidiary of Parent (the “ Seller ”) and (iv) Realbotix, LLC, a Delaware limited liability company and wholly owned subsidiary of the Seller (the “ Company ” or “ Realbotix ”).”